PAVmed (NASDAQ:PAVM) Share Price Crosses Below 50-Day Moving Average of $2.19

PAVmed Inc. (NASDAQ:PAVM) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.19 and traded as low as $1.81. PAVmed shares last traded at $1.97, with a volume of 30,577 shares changing hands.

PAVmed Price Performance

The stock has a market capitalization of $18.06 million, a P/E ratio of -0.21 and a beta of 0.85. The firm has a 50 day moving average of $2.19 and a 200-day moving average of $3.13.

Hedge Funds Weigh In On PAVmed

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. increased its stake in PAVmed by 5.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 195,167 shares of the company’s stock valued at $258,000 after acquiring an additional 10,458 shares during the period. Verition Fund Management LLC bought a new stake in shares of PAVmed in the 1st quarter valued at approximately $196,000. Wells Fargo & Company MN grew its stake in shares of PAVmed by 18.6% in the 4th quarter. Wells Fargo & Company MN now owns 366,570 shares of the company’s stock valued at $176,000 after purchasing an additional 57,533 shares during the period. Lido Advisors LLC grew its stake in shares of PAVmed by 400.0% in the 1st quarter. Lido Advisors LLC now owns 50,000 shares of the company’s stock valued at $66,000 after purchasing an additional 40,000 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in shares of PAVmed by 108.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 72,609 shares of the company’s stock valued at $62,000 after purchasing an additional 37,724 shares during the period. 19.93% of the stock is currently owned by institutional investors.

PAVmed Company Profile

PAVmed Inc operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay.